Please login to the form below

Not currently logged in


This page shows the latest Zepatier news and features for those working in and with pharma, biotech and healthcare.

Merck & Co joins big pharma pricing pledge – but sceptics unconvinced

Merck & Co joins big pharma pricing pledge – but sceptics unconvinced

Thus while it has pledged a 60% cut to the list price of its hepatitis drug Zepatier, sales of the product are so low that after paying rebates to insurers, the

Latest news

More from news
Approximately 6 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....